Experienced in Carcinoid Syndrome

Dr. Cheryl A. Carlson

Hematology Oncology
1959 Ne Pacific St, C212, Box 356340, 
Seattle, WA 
Experienced in Carcinoid Syndrome
1959 Ne Pacific St, C212, Box 356340, 
Seattle, WA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Cheryl Carlson is a Hematologist Oncology provider in Seattle, Washington. Dr. Carlson is rated as an Experienced provider by MediFind in the treatment of Carcinoid Syndrome. Her top areas of expertise are Lynch Syndrome, Gastrointestinal Stromal Tumor, Undifferentiated Pleomorphic Sarcoma, Mesenchymoma, and Bone Marrow Aspiration.

Her clinical research consists of co-authoring 4 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Licenses
Internal Medicine in WA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

1959 Ne Pacific St, C212, Box 356340, Seattle, WA 98195

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Other, Procedure, Drug
Study Drugs: Atezolizumab, 5-Fluorouracil, Leucovorin, Oxaliplatin
Study Phase: Phase 3
Phase II Single-arm Study of the Combination of Palbociclib and Cetuximab in KRAS/NRAS/BRAF Wild-type Metastatic Colorectal Cancer
Phase II Single-arm Study of the Combination of Palbociclib and Cetuximab in KRAS/NRAS/BRAF Wild-type Metastatic Colorectal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 22, 2025
Intervention Type: Drug
Study Drugs: Cetuximab, Palbociclib
Study Phase: Phase 2
Phase II Multicenter Trial of Panitumumab, Nivolumab, and Ipilimumab for KRAS/NRAS/BRAF Wild-type MSS Refractory Metastatic Colorectal Adenocarcinoma
Phase II Multicenter Trial of Panitumumab, Nivolumab, and Ipilimumab for KRAS/NRAS/BRAF Wild-type MSS Refractory Metastatic Colorectal Adenocarcinoma
Enrollment Status: Completed
Publish Date: July 01, 2025
Intervention Type: Drug
Study Drugs: Panitumumab, Nivolumab, Ipilimumab
Study Phase: Phase 2
Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients with Previously Untreated Metastatic Colorectal Cancer (SOLARIS)
Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients with Previously Untreated Metastatic Colorectal Cancer (SOLARIS)
Enrollment Status: Active_not_recruiting
Publish Date: January 13, 2025
Intervention Type: Other, Dietary supplement, Drug
Study Drugs: Bevacizumab, Oxaliplatin, Leucovorin calcium, Fluorouracil, Irinotecan hydrochloride, Irinotecan
Study Phase: Phase 3
Quantification and Characterization of Circulating Tumor Cells in Solid Tumors
Quantification and Characterization of Circulating Tumor Cells in Solid Tumors
Enrollment Status: Completed
Publish Date: September 28, 2022
Intervention Type: Other
A Biologic Study of Global Gene Expression, NF-Kappa B and p53 in Adenocarcinoma of the Rectum.
A Biologic Study of Global Gene Expression, NF-Kappa B and p53 in Adenocarcinoma of the Rectum.
Enrollment Status: Completed
Publish Date: August 11, 2022
Intervention Type: Drug, Procedure, Radiation
View 5 Less Clinical Trials

4 Total Publications

Disseminating MSSA Infection in a Preterm Infant With Rare Finding of Spinal Epidural Abscess: A Case Report.
Disseminating MSSA Infection in a Preterm Infant With Rare Finding of Spinal Epidural Abscess: A Case Report.
Journal: Advances in neonatal care : official journal of the National Association of Neonatal Nurses
Published: March 10, 2023
Similar Doctors
Distinguished in Carcinoid Syndrome
Dr. William T. Purcell
Hematology Oncology | Hematology | Oncology
Distinguished in Carcinoid Syndrome
Dr. William T. Purcell
Hematology Oncology | Hematology | Oncology

The Association Of University Physicians

825 Eastlake Ave E, 
Seattle, WA 
 (1.9 miles away)
206-288-1000
Languages Spoken:
English, Bengali, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

William Purcell is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Purcell is rated as a Distinguished provider by MediFind in the treatment of Carcinoid Syndrome. His top areas of expertise are Neuroendocrine Tumor, Lung Cancer, Carcinoid Syndrome, Non-Small Cell Lung Cancer (NSCLC), and Tissue Biopsy. Dr. Purcell is currently accepting new patients.

Advanced in Carcinoid Syndrome
Dr. Francis M. Senecal
Hematology Oncology | Hematology | Oncology
Advanced in Carcinoid Syndrome
Dr. Francis M. Senecal
Hematology Oncology | Hematology | Oncology

Northwest Medical Specialties PLLC

11511 Canterwood Blvd, Suite 45, 
Gig Harbor, WA 
 (24.4 miles away)
253-428-8700
Languages Spoken:
English, Castilian, Dutch, Konkani, Korean, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Francis Senecal is a Hematologist Oncology specialist and a Hematologist in Gig Harbor, Washington. Dr. Senecal is rated as a Distinguished provider by MediFind in the treatment of Carcinoid Syndrome. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Bone Marrow Aspiration. Dr. Senecal is currently accepting new patients.

Advanced in Carcinoid Syndrome
Dr. Blair B. Irwin
Hematology Oncology | Hematology | Oncology
Advanced in Carcinoid Syndrome
Dr. Blair B. Irwin
Hematology Oncology | Hematology | Oncology

Multicare Health System

4545 Point Fosdick Dr, 
Gig Harbor, WA 
 (27.3 miles away)
253-530-8011
Experience:
17+ years
Languages Spoken:
English, Arabic, Filipino, Hebrew, Russian, Spanish, Thai, Ukrainian, Vietnamese
See accepted insurances
Accepting New Patients
Offers Telehealth

Blair Irwin is a Hematologist Oncology specialist and a Hematologist in Gig Harbor, Washington. Dr. Irwin has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Carcinoid Syndrome. Her top areas of expertise are Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Pleuropulmonary Blastoma. Dr. Irwin is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Carlson's expertise for a condition
ConditionClose
      View All 34 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile